- Report
- February 2026
- 200 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 184 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 172 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 262 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 299 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 263 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 188 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 335 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 293 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 193 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 158 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 299 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 413 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 295 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 383 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 172 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 504 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 268 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 376 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 283 Pages
Global
From €5103EUR$5,850USD£4,444GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more